clinical development of olinvacimab part 2/2, at bioplus interphex korea 2020
Published 4 years ago • 238 plays • Length 5:58Download video MP4
Download video MP3
Similar videos
-
4:21
clinical developmnet of olinvacimab part 1/2, at bioplus interphex korea 2020
-
4:45
introduction of integrative brain disorder society (korean interview, english subtitle)
-
16:34
part 2: advances in lipid emulsions: emergence of clinolipid
-
14:48
clinical development of apoa2-isoform as blood biomarker for early detection of pancreatic cancer
-
![[multidisciplinary] ich m3(r2)](https://i.ytimg.com/vi/JscBrOWH3k8/mqdefault.jpg)
1:13:50
[multidisciplinary] ich m3(r2)
-
![[introductory session] ich](https://i.ytimg.com/vi/AWH3h7sqPHo/mqdefault.jpg)
16:36
[introductory session] ich
-
2:13
가천대학교 가천융합의과학원 신입생 모집안내
-
![[efficacy] ich e2b(r3) - china](https://i.ytimg.com/vi/LGTOVhdCPhM/mqdefault.jpg)
37:05
[efficacy] ich e2b(r3) - china
-
![[bix2022] bix 2022 conference sessions – day 3](https://i.ytimg.com/vi/J_1VTnjWhh0/mqdefault.jpg)
3:24
[bix2022] bix 2022 conference sessions – day 3
-
![[business session] [cytiva] the introduction of global biopharma index (korea part)](https://i.ytimg.com/vi/exJA0wWtYsc/mqdefault.jpg)
28:43
[business session] [cytiva] the introduction of global biopharma index (korea part)
-
0:45
korea's biosimilar drug market to nearly double by 2019
-
2:57:23
gmt20241009 130236 recording 1920x1080 ap1 chap 2 p1
-
1:07:05
the 2st international editor forum of clinical and molecular hepatology
-
2:30
bioplus-interphex korea 2022: latest bio-pharmaceutical technologies showcased in global exhibition
-
![[efficacy] ich e2b(r3) - korea](https://i.ytimg.com/vi/xRP91ANWXAs/mqdefault.jpg)
27:23
[efficacy] ich e2b(r3) - korea
-
![[multidisciplinary] m12_eng](https://i.ytimg.com/vi/n0fvUgsWOjo/mqdefault.jpg)
1:01:20
[multidisciplinary] m12_eng
-
31:37
the two cryptic species of plasmodium ovale
-
![[dr. hanui’s korean medicine health class] 2. post-covid conditions](https://i.ytimg.com/vi/T2PbjzrQJ58/mqdefault.jpg)
3:35
[dr. hanui’s korean medicine health class] 2. post-covid conditions
-
![[multidisciplinary] m3(r2)](https://i.ytimg.com/vi/O3JJjeh13SU/mqdefault.jpg)
1:01:31
[multidisciplinary] m3(r2)
-
![[technical session] trends in drug development: innovation and analysis. adoption with covid 19](https://i.ytimg.com/vi/3uSd9sG-gkQ/mqdefault.jpg)
1:57:19
[technical session] trends in drug development: innovation and analysis. adoption with covid 19